Loading...
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
Concurrent/adjuvant cisplatin-based chemoradiotherapy is regarded as the standard of treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). However, patients who do not respond to cisplatin suffer, rather than benefit, from chemotherapy treatment. The goal of this study was to identif...
Na minha lista:
| Udgivet i: | Cell Death Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520926/ https://ncbi.nlm.nih.gov/pubmed/28617432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.271 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|